New York S 6332: Limits the substitution of abuse-deterrent analgesic opioid drug products for analgesic opioids lacking such technology

Status: REFERRED TO HEALTH (as of 2024-01-03)

State: New York · Session: 2023-2024 · Bill: S 6332

Sponsors: Samra Brouk

View New York S 6332 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.